Cargando…

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?

Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhary, Om Prakash, Priyanka, Ahmed, Jivan Q., Mohammed, Teroj A., Singh, Indraj, Rodriguez-Morales, Alfonso J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726007/
https://www.ncbi.nlm.nih.gov/pubmed/34898381
http://dx.doi.org/10.1080/21645515.2021.2007015
_version_ 1784626234556153856
author Choudhary, Om Prakash
Priyanka,
Ahmed, Jivan Q.
Mohammed, Teroj A.
Singh, Indraj
Rodriguez-Morales, Alfonso J.
author_facet Choudhary, Om Prakash
Priyanka,
Ahmed, Jivan Q.
Mohammed, Teroj A.
Singh, Indraj
Rodriguez-Morales, Alfonso J.
author_sort Choudhary, Om Prakash
collection PubMed
description Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the rapidly emerging SARS-CoV-2 variants. Many studies have been conducted on the heterologous prime-boost vaccine regimens and have shown good efficacy results against COVID-19. This article aims to highlight the safety and reliability of heterologous prime-boost vaccination against COVID-19. We have also made some recommendations towards using these combinations of vaccines for the global mitigation of the subsequent waves of COVID-19.
format Online
Article
Text
id pubmed-8726007
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-87260072022-01-05 Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? Choudhary, Om Prakash Priyanka, Ahmed, Jivan Q. Mohammed, Teroj A. Singh, Indraj Rodriguez-Morales, Alfonso J. Hum Vaccin Immunother Commentary Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the rapidly emerging SARS-CoV-2 variants. Many studies have been conducted on the heterologous prime-boost vaccine regimens and have shown good efficacy results against COVID-19. This article aims to highlight the safety and reliability of heterologous prime-boost vaccination against COVID-19. We have also made some recommendations towards using these combinations of vaccines for the global mitigation of the subsequent waves of COVID-19. Taylor & Francis 2021-12-13 /pmc/articles/PMC8726007/ /pubmed/34898381 http://dx.doi.org/10.1080/21645515.2021.2007015 Text en © 2021 Taylor & Francis Group, LLC
spellingShingle Commentary
Choudhary, Om Prakash
Priyanka,
Ahmed, Jivan Q.
Mohammed, Teroj A.
Singh, Indraj
Rodriguez-Morales, Alfonso J.
Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
title Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
title_full Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
title_fullStr Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
title_full_unstemmed Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
title_short Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
title_sort heterologous prime-boost vaccination against covid-19: is it safe and reliable?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726007/
https://www.ncbi.nlm.nih.gov/pubmed/34898381
http://dx.doi.org/10.1080/21645515.2021.2007015
work_keys_str_mv AT choudharyomprakash heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable
AT priyanka heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable
AT ahmedjivanq heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable
AT mohammedteroja heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable
AT singhindraj heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable
AT rodriguezmoralesalfonsoj heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable